Generically known as Gliclazide, Damecon works as a hypoglycemic agent with side effects such as hypoglycemia, gastrointestinal disturbances, and skin rash. The medication should be used in accordance with medical advice. Gliclazide is an oral sulfonylurea hypoglycemic agent, which is used to stimulate insulin secretion from pancreatic β-cells to lower blood glucose levels, and is indicated for patients with non-insulin-dependent type 2 diabetes mellitus. It is indicated for patients with non-insulin-dependent type 2 diabetes mellitus. The drug may cause various side effects, such as hypoglycemia, nausea, dyspepsia, diarrhea, constipation, rash, itching, decreased blood cells, and abnormal liver function. This drug is contraindicated in allergy, insulin-dependent diabetes mellitus patients, severe hepatic and renal insufficiency, and lactating women. Diabetic patients must use the drug under the guidance of a physician, and regular monitoring of blood glucose, if there is any adverse reaction after the use of the drug, you need to stop the drug in time to seek medical attention.